Interview with Jean Marimbert, Director General, Agence Française de Sécurité…
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
Thépenier Pharma, a subsidiary of the Japanese group Nippon Shikizai, has specialized in custom work for a full range of topical products for the last 50 years, and specializes in particular in Oral Care. Thépenier Pharma manufactures and packages pharmaceutical products, medical devices, oral care products, and skin care products formulated as pastes, liquids, or powder. Thepenier Pharma achieved revenues at around 14 million Euros (15.4 million USD) in 2015, of which 60% come from exports. Located not far from Paris and the port of Le Havre port, the company’s factories ensure easy accessibility and favorable supply from France and internationally.
Contact
Route departementale 912
61400 Saint-Langis-les-Mortagne
Téléphone : +33 02 33 85 22 22
Email : info@thepenier-pharma.fr
The creation of AFSSAPS in 1999 was a milestone for the industry as it became the organism which gives authorization to enter a drug into the market. Can you explain…
The US chooses to price its innovative drugs based on a market approach which is very different from the French system. Could you explain how the French model rewards innovative…
What was the idea behind the creation of the « Etats Generaux de l’industrie » (General States of Industries)? What can we expect from them? The main idea is that…
See our Cookie Privacy Policy Here
